Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

Merck KGaA. (6/12/14). "Press Release: Merck and Schüssler Novachem Reach Agreement on Sale of Assets of Chemische Fabrik Lehrte. Merck Sells Laboratory Equipment and Production Units to Schüssler Novachem". Darmstadt.

Organisations Organisation Merck KGaA
  Group Merck (DE) (Group)
  Organisation 2 Chemische Fabrik Lehrte Dr. Andreas Kossel GmbH (CFL)
  Group Schüssler Novachem (DE)
Product Product CHEMICALS
Person Person Reckmann, Bernd (Merck KGaA 1986–201604 Executive Board Member since 2007 RETIRED 4/16))
     


> Merck sells laboratory equipment and production units to Schüssler Novachem

> Merck to exit Lehrte site as planned at the end of June


Merck, a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors, and Schüssler Novachem, a manufacturer of inorganic salts based in Halle/Saale, Germany, have reached an agreement on the sale of laboratory equipment and production units located at the Lehrte site in the German federal state of Lower Saxony. The parties have agreed not to disclose the selling price or further details of the transaction. Schüssler had already acquired the land and buildings in Lehrte from Deutsche Bahn Immobilien GmbH in a separate transaction.

"We are glad to see that Schüssler will continue with their own chemical production at the Lehrte location," said Bernd Reckmann, CEO Chemicals at Merck.

As part of its "Fit for 2018" transformation and growth program, Merck announced in 2012 that it would close the Lehrte site in mid-2014 and continue to operate the relevant business from Darmstadt. Therefore Merck and the works council agreed about a reconciliation of interest and a social plan. Apart from efficiency enhancement measures, "Fit for 2018" also comprises numerous investments to secure future growth across various segments of the business: a recent example of supporting growth has been the construction of new powerplants at Merck's corporate center in Darmstadt since August 2013.


All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website www.merckgroup.com/media. Please go to http://www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.


Merck is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. With its four divisions Merck Serono, Consumer Health, Performance Materials and Merck Millipore, Merck generated total revenues of € 11.1 billion in 2013. Around 38,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck is the world's oldest pharmaceutical and chemical company - since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company is known as EMD.

   
Record changed: 2017-04-02

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px




» top